BACKGROUND: The European Atherosclerosis Research Study (EARS) I had shown that fasting plasma concentrations of apolipoprotein B (apo B) and triglycerides were the most discriminant variables between offspring with a paternal history of coronary heart disease (CHD) and controls. The EARS II study was undertaken to investigate whether a paternal history of CHD was associated with differences in postprandial lipemia. DESIGN: Male subjects with a paternal history of CHD (cases, n = 407) and age-matched male controls (n = 415) were recruited from 14 European universities. All subjects had an oral fat tolerance test. RESULTS: In the sample as a whole, the postprandial triglyceride responses did not significantly differ between the two groups. However, in the upper tertile of fasting triglycerides, cases displayed a higher area under the curve (5.71 vs. 4.49 mmol.h L-1, P < 0.001), a higher peak (1.76 vs. 1.43 mmol L-1, P < 0.001) and a more delayed time to peak (3.15 vs. 2.91 h, P < 0.05) than controls. In the upper tertile, fasting apo B levels (P < 0.05) and triglyceride area under the curve (P = 0.002) significantly discriminated cases from controls in a multivariate analysis. Cases had also higher Lp C-III:B levels at 4 h than controls (11.2 vs. 9.9 mg dL-1, P < 0.01) and this difference remained significant after adjustment for apo B and triglyceride levels. CONCLUSIONS: These results indicate that in subjects with a moderate elevation of fasting triglycerides, an impaired postprandial response to a fat load constitutes an early biological expression of a paternal history of premature CHD.
BACKGROUND: The European Atherosclerosis Research Study (EARS) I had shown that fasting plasma concentrations of apolipoprotein B (apo B) and triglycerides were the most discriminant variables between offspring with a paternal history of coronary heart disease (CHD) and controls. The EARS II study was undertaken to investigate whether a paternal history of CHD was associated with differences in postprandial lipemia. DESIGN: Male subjects with a paternal history of CHD (cases, n = 407) and age-matched male controls (n = 415) were recruited from 14 European universities. All subjects had an oral fat tolerance test. RESULTS: In the sample as a whole, the postprandial triglyceride responses did not significantly differ between the two groups. However, in the upper tertile of fasting triglycerides, cases displayed a higher area under the curve (5.71 vs. 4.49 mmol.h L-1, P < 0.001), a higher peak (1.76 vs. 1.43 mmol L-1, P < 0.001) and a more delayed time to peak (3.15 vs. 2.91 h, P < 0.05) than controls. In the upper tertile, fasting apo B levels (P < 0.05) and triglyceride area under the curve (P = 0.002) significantly discriminated cases from controls in a multivariate analysis. Cases had also higher Lp C-III:B levels at 4 h than controls (11.2 vs. 9.9 mg dL-1, P < 0.01) and this difference remained significant after adjustment for apo B and triglyceride levels. CONCLUSIONS: These results indicate that in subjects with a moderate elevation of fasting triglycerides, an impaired postprandial response to a fat load constitutes an early biological expression of a paternal history of premature CHD.
Authors: Oliver T Bruns; Harald Ittrich; Kersten Peldschus; Michael G Kaul; Ulrich I Tromsdorf; Joachim Lauterwasser; Marija S Nikolic; Birgit Mollwitz; Martin Merkel; Nadja C Bigall; Sameer Sapra; Rudolph Reimer; Heinz Hohenberg; Horst Weller; Alexander Eychmüller; Gerhard Adam; Ulrike Beisiegel; Joerg Heeren Journal: Nat Nanotechnol Date: 2009-01-25 Impact factor: 39.213
Authors: Pablo Perez-Martinez; Juan F Alcala-Diaz; Edmon K Kabagambe; Antonio Garcia-Rios; Michael Y Tsai; Javier Delgado-Lista; Genovefa Kolovou; Robert J Straka; Francisco Gomez-Delgado; Paul N Hopkins; Carmen Marin; Ingrid Borecki; Elena M Yubero-Serrano; James E Hixson; Antonio Camargo; Michael A Province; Javier Lopez-Moreno; Fernando Rodriguez-Cantalejo; Francisco J Tinahones; Dimitri P Mikhailidis; Francisco Perez-Jimenez; Donna K Arnett; Jose M Ordovas; Jose Lopez-Miranda Journal: J Clin Lipidol Date: 2016-06-01 Impact factor: 4.766
Authors: M C Smart; G Dedoussis; N Yiannakouris; M L Grisoni; G K Dror; M Yannakoulia; C Papoutsakis; E Louizou; C S Mantzoros; L Melistas; M D Kontogianni; J A Cooper; S E Humphries; P J Talmud Journal: Nutr Metab Cardiovasc Dis Date: 2010-03-12 Impact factor: 4.222
Authors: Loes P M Duivenvoorde; Evert M van Schothorst; Hans M Swarts; Ondrej Kuda; Esther Steenbergh; Sander Termeulen; Jan Kopecky; Jaap Keijer Journal: PLoS One Date: 2015-06-22 Impact factor: 3.240